Flavocure Biotech, Inc. — Form D
Flavocure Biotech, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-04. The offering totals $1.3M, of which $1.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-01-04
- Form: D
- Accession: 0001960342-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $1.1M
- Remaining: $125K
- Minimum investment: $25K
- Investors: 3
- Date of first sale: 2022-12-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-469638
Issuer
- Name: Flavocure Biotech, Inc.
- CIK: 0001960342
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 701 E PRATT ST, BALTIMORE, MD, 21202
- Phone: 240-381-7329
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| David Brooks | Executive Officer | New York, NY |
| Thomas Lang | Executive Officer | Dublin, OH |
| Eric Chapman | Promoter | Cumberland, ME |
| Anthony Deasey | Promoter | Severna Park, MD |
| Saurabh Sewak | Promoter | Winchester, MA |
| Swen Simms | Promoter | Kingston 20, L8 |
| Theresia Toyeng | Promoter | Elkridge, MD |
| David Traylor | Promoter | Centennial, CO |
| Ngeh Toyang | Director | Baltimore, MD |
| Ngeh Toyang | Executive Officer | Baltimore, MD |
| Justin Grant | Director | Baltimore, MD |
| Henry Lowe | Director | Baltimore, MD |
| Henry Lowe | Executive Officer | Baltimore, MD |
| Douglas Liu | Executive Officer | Baltimore, MD |
Other filings by this issuer (1)
More